🇺🇸 FDA
Patent

US 6376467

Use of inhibitors of protein kinase C epsilon to treat pain

expired A61KA61K38/45

Quick answer

US patent 6376467 (Use of inhibitors of protein kinase C epsilon to treat pain) held by The Regents of the University of California expires Mon Apr 18 2022 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Apr 23 2002 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 18 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
4
CPC classes
A61K, A61K38/45